147 related articles for article (PubMed ID: 25838588)
1. Comparison of neostigmine induced reversal of vecuronium in normal weight, overweight and obese female patients.
Joshi SB; Upadhyaya KV; Manjuladevi M
Indian J Anaesth; 2015 Mar; 59(3):165-70. PubMed ID: 25838588
[TBL] [Abstract][Full Text] [Related]
2. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
Suzuki T; Masaki G; Ogawa S
Br J Anaesth; 2006 Aug; 97(2):160-3. PubMed ID: 16782976
[TBL] [Abstract][Full Text] [Related]
3. Dose-reversal effect relationship of three different doses of neostigmine in obese patients: A randomised clinical trial.
Parida S; Kausalya V; Mishra SK; Adinarayanan S
Indian J Anaesth; 2017 Oct; 61(10):787-792. PubMed ID: 29242649
[TBL] [Abstract][Full Text] [Related]
4. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
[TBL] [Abstract][Full Text] [Related]
5. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
6. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
[TBL] [Abstract][Full Text] [Related]
7. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
8. Epidurally administered mepivacaine delays recovery of train-of-four ratio from vecuronium-induced neuromuscular block.
Suzuki T; Mizutani H; Ishikawa K; Miyake E; Saeki S; Ogawa S
Br J Anaesth; 2007 Nov; 99(5):721-5. PubMed ID: 17855735
[TBL] [Abstract][Full Text] [Related]
9. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade.
Kim KS; Oh YN; Kim TY; Oh SY; Sin YH
Korean J Anesthesiol; 2016 Jun; 69(3):239-43. PubMed ID: 27274368
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine.
Fuchs-Buder T; Ziegenfuss T; Lysakowski K; Tassonyi E
Br J Anaesth; 1999 Jan; 82(1):61-5. PubMed ID: 10325838
[TBL] [Abstract][Full Text] [Related]
11. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?
Magorian TT; Lynam DP; Caldwell JE; Miller RD
Anesthesiology; 1990 Sep; 73(3):410-4. PubMed ID: 1975484
[TBL] [Abstract][Full Text] [Related]
12. Edrophonium is better than neostigmine to antagonize residual vecuronium induced neuromuscular block.
Puura AI; Baer GA; Rorarius MG
Acta Anaesthesiol Belg; 1994; 45(4):161-6. PubMed ID: 7887118
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey.
Staals LM; van Egmond J; Driessen JJ; de Boer HD; van de Pol F; Bom AH; Booij LH
Eur J Anaesthesiol; 2011 Apr; 28(4):265-72. PubMed ID: 21157358
[TBL] [Abstract][Full Text] [Related]
14. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
15. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block.
Suzuki T; Fukano N; Kitajima O; Saeki S; Ogawa S
Br J Anaesth; 2006 Jan; 96(1):44-7. PubMed ID: 16299046
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
Caldwell JE; Robertson EN; Baird WL
Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
[TBL] [Abstract][Full Text] [Related]
17. Speed of reversal of vecuronium neuromuscular block with different doses of neostigmine in anesthetized dogs.
Martin-Flores M; Lorenzutti AM; Litterio NJ; Rossetti VL; Zarazaga MP; Bonetto CC; Aguirre GE
Vet Anaesth Analg; 2017 Jan; 44(1):28-34. PubMed ID: 27258375
[TBL] [Abstract][Full Text] [Related]
18. [Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
Izawa H; Takeda J; Fukushima K
Masui; 1997 Feb; 46(2):177-83. PubMed ID: 9071099
[TBL] [Abstract][Full Text] [Related]
19. Observational study on patterns of neuromuscular blockade reversal.
Dubovoy T; Housey M; Devine S; Kheterpal S
BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
[TBL] [Abstract][Full Text] [Related]
20. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
Dhonneur G; Rebaine C; Slavov V; Ruggier R; De Chaubry V; Duvaldestin P
Anesth Analg; 1996 Jan; 82(1):134-8. PubMed ID: 8712389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
